Dementia QUEST®
Committed to highlighting research and other effective scientific efforts in the development of solutions to prevent, early-detect, and intervene to combat Dementia.
Important Notice: This list below is primarily intended to highlight solutions that may be of help to you, and the Dementia community at large. Dementia Society of America (DSA) is not liable for statements or omissions made by the creators, researchers, developers, manufacturers, distributors, marketers, and/or sales representatives, et al, about their products, services or work output. DSA is not liable for any failure of the products or services to work as intended; to work as advertised, or to fit their particular purpose. Dementia Society of America does not endorse, or take an ownership interest in any of the companies, individuals, devices, software applications, solutions or services, etc., listed or mentioned in any of our electronic, printed or verbal communications.
The links below will open websites in a separate web browser page, so you can keep your place here.
Interested in the efforts to explore medical cannabis? Click here.
DEMENTIA QUEST® RESEARCH RECOGNITION AWARD
Question | Understand | Evaluate | Select | Test
Dementia QUEST program is based on the traditional constructs of the scientific method and discovery. We award recognition to organizations, inventors, researchers, and others that are demonstrating leadership in their fields for the purposes of advancing brain health and Dementia-related innovations.
Are you doing innovative research? We encourage you to learn more and apply for the Dementia QUEST Award by contacting us.
C2N Diagnostics
Dementia Quest® Award Winner
The PrecivityAD™ test from C2N Diagnostics, LLC is an innovative new blood test for patients with cognitive impairment. The test aims to help physicians better determine the presence or absence of amyloid plaques in the brain, a hallmark sign of Alzheimer’s disease. www.precivityad.com
Xiaojing Gao, Ph.D., Stanford University
DSA Seed Grant Winner
Project Title: When Neural Circuits Meet Molecular Circuits: Quantitative Genetic Manipulation with Single-cell Consistency.
Engineered viruses (“vectors”) can serve as “trojan horses” for delivering gene products into cells. Such viral vectors are powerful tools for interrogating neural circuits and treating neurological diseases [such as those that can cause Dementia]. Learn more here.
Akhila Rajan, Ph.D., Fred Hutchinson
DSA Seed Grant Winner
Project Title: Fat to Brain Communication: Inter-organ Transport of Mitochondrial Molecules. Increased life expectancy has resulted in a higher incidence of age-related Dementia, but treatments remain elusive. Obesity has been established as an independent risk factor for developing dementia. Yet, the mechanisms [for developing] late-life Dementia remain largely unknown. This proposal seeks to address this fundamental gap. Learn more here.